Dylan is the Founder & CEO of Mindbloom, an NYC-based mental health and wellbeing startup helping people expand their human potential with clinician-prescribed, guided psychedelic medicine experiences. There, he is partnering with clinicians, technologists, researchers, and patients to increase access to science-backed treatments, starting by reducing the cost of ketamine therapy for depression and anxiety by over 65%.
Dylan is a 10-year psychedelic medicine patient and 3-time tech entrepreneur with both $100M+ in funding and an exit in his prior startups, which were focused on increasing access to justice and democracy. Dylan graduated from The Wharton School at The University of Pennsylvania.
1:08 - My background with anxiety and being a Mindbloom patient
9:27 - Background on Mindbloom
11:50 - Dylan's personal experience with psychedelics
16:47 - How Mindbloom is making ketamine accessible with telemedicine
22:36 - The different ways to take ketamine
24:46 - Ketamine dosing
27:20 - What a Mindbloom experience is like
31:23 - The importance of focus when building a startup
36:27 - Should psychedelics be legal
39:28 - How Dylan is building company culture at Mindbloom
Full Show Notes, Transcript and YouTube Clips can be found at www.mindthings.co/dylan-beynon/
Follow us on Twitter: @mindthingsco
Subscribe to our newsletter
Follow us on YouTube